Active immunization using dendritic cells mixed with tumor cells inhibits the growth of primary breast cancer

This publication has 21 references indexed in Scilit:

• B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes.
  The Journal of Experimental Medicine, 1996
• Recent advances in the study of dendritic cells and follicular dendritic cells
  Immunology Today, 1995
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo
  European Journal of Immunology, 1994
• Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells
  European Journal of Immunology, 1994
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
  The Journal of Experimental Medicine, 1992
• Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo.
  The Journal of Experimental Medicine, 1992
• The Dendritic Cell System and its Role in Immunogenicity
  Annual Review of Immunology, 1991
• Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins.
  The Journal of Experimental Medicine, 1990
• An antigen-independent contact mechanism as an early step in T cell-proliferative responses to dendritic cells.
  The Journal of Experimental Medicine, 1989